227
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for partial onset seizures

, , &
Pages 415-431 | Published online: 17 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lan Gao & Shuchuen Li. (2016) Emerging drugs for partial-onset epilepsy: a review of brivaracetam. Therapeutics and Clinical Risk Management 12, pages 719-734.
Read now

Articles from other publishers (5)

Sara Meirinho, Márcio Rodrigues, Ana Fortuna, Amílcar Falcão & Gilberto Alves. (2021) Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review. Journal of Pharmaceutical Analysis 11:4, pages 405-421.
Crossref
Wolfgang Löscher, Graeme J. Sills & H. Steve White. (2021) The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?. Epilepsia 62:3, pages 596-614.
Crossref
Jacklyn A. Harris & Julie A. Murphy. (2011) Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians. Therapeutic Advances in Chronic Disease 2:6, pages 371-376.
Crossref
Władysław Lasoń, Monika Dudra-Jastrzębska, Konrad Rejdak & Stanisław J. Czuczwar. (2011) Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacological Reports 63:2, pages 271-292.
Crossref
Ismet Dorange & Britt-Marie Swahn. 2011. 53 65 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.